4-Androstenedione
Results: 5
| # | Item |
|---|---|
1 | WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LISTAdd to Reading ListSource URL: www.westend69ers.deLanguage: English - Date: 2016-04-06 10:54:29 |
2 | WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LISTAdd to Reading ListSource URL: www.bowlssa.co.zaLanguage: English - Date: 2016-01-18 01:12:47 |
3![AROMASIN® (exemestane tablets) NDA[removed]S-006 October 4, 2005 S-006 Approved Labeling EBC Indication](https://www.pdfsearch.io/img/d4d88db0b10edef86ba642672276cdda.jpg "AROMASIN® (exemestane tablets) NDA[removed]S-006 October 4, 2005 S-006 Approved Labeling EBC Indication") | AROMASIN® (exemestane tablets) NDA[removed]S-006 October 4, 2005 S-006 Approved Labeling EBC IndicationAdd to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 15:16:10 |
4 | PDF DocumentAdd to Reading ListSource URL: www.fda.govLanguage: English - Date: 2003-02-04 14:56:40 |
5![December[removed]INTRODUCTION This report is the quarterly summary of all data reported within the specified data-reporting period for Quarter 4, 2013. The attached tables provide the certification profiles for the distrib](https://www.pdfsearch.io/img/088f5b689232d10186959da18f2eb999.jpg "December[removed]INTRODUCTION This report is the quarterly summary of all data reported within the specified data-reporting period for Quarter 4, 2013. The attached tables provide the certification profiles for the distrib") | December[removed]INTRODUCTION This report is the quarterly summary of all data reported within the specified data-reporting period for Quarter 4, 2013. The attached tables provide the certification profiles for the distribAdd to Reading ListSource URL: www.cdc.govLanguage: English - Date: 2013-12-12 07:26:45 |